Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Dec;37(4):503-510.
doi: 10.1016/j.bpa.2023.10.003. Epub 2023 Oct 16.

Preoperative iron therapy: Where are we?

Affiliations
Free article
Review

Preoperative iron therapy: Where are we?

Beth MacLean et al. Best Pract Res Clin Anaesthesiol. 2023 Dec.
Free article

Abstract

Preoperative anemia affects one-third of patients undergoing major surgery and is associated with worse perioperative and postoperative outcomes; including length of hospital stay, allogeneic blood transfusion, morbidity, and mortality. Iron deficiency is the most common cause of anemia, and associative data suggests that preoperative correction of iron deficiency anemia could improve postoperative patient outcomes. However, data from randomized controlled trials (RCTs) do not appear to support the routine use of iron therapy to treat preoperative anemia. We present a literature review of large RCTs examining the efficacy of preoperative intravenous iron. We discuss the observation that although preoperative intravenous iron treatment can increase hemoglobin concentration prior to surgery in certain patient groups, the data do not clarify whether there is a direct benefit to patients. We address that preoperative intravenous iron may not be a feasible option and highlight the need to explore the mechanism and management of iron deficiency anemia in surgical patients.

Keywords: Anemia; Blood; Iron; Iron deficiencies; Surgery.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest This article was not funded. BM, ACW and JL have no COI to declare. TR was the Coordinating Principal Investigator for the PREVENTT trial and has received financial support from Pharmacosmos, Vifor Pharma and Viatris for grants and personal fees in the past.

MeSH terms

LinkOut - more resources